Drug Shortage Report for LOPERAMIDE-2
| Report ID | 61249 |
| Drug Identification Number | 02225182 |
| Brand name | LOPERAMIDE-2 |
| Common or Proper name | LOPERAMIDE |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | LOPERAMIDE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | A07DA |
| ATC description | ANTIPROPULSIVES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-09-11 |
| Estimated end date | |
| Actual end date | 2018-12-05 |
| Shortage status | Resolved |
| Updated date | 2018-12-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-12-06 | English | Compare |
| v5 | 2018-12-05 | French | Compare |
| v4 | 2018-12-05 | English | Compare |
| v3 | 2018-09-12 | English | Compare |
| v2 | 2018-09-11 | French | Compare |
| v1 | 2018-09-11 | English | Compare |
Showing 1 to 6 of 6